Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat.

Swanson CJ, Perry KW, Koch-Krueger S, Katner J, Svensson KA, Bymaster FP.

Neuropharmacology. 2006 May;50(6):755-60. Epub 2006 Jan 19.

PMID:
16427661
2.

Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.

Koda K, Ago Y, Cong Y, Kita Y, Takuma K, Matsuda T.

J Neurochem. 2010 Jul;114(1):259-70. doi: 10.1111/j.1471-4159.2010.06750.x. Epub 2010 Apr 16.

3.

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.

Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW.

Neuropsychopharmacology. 2002 Nov;27(5):699-711.

4.

Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine.

Tzavara ET, Bymaster FP, Overshiner CD, Davis RJ, Perry KW, Wolff M, McKinzie DL, Witkin JM, Nomikos GG.

Mol Psychiatry. 2006 Feb;11(2):187-95.

PMID:
16231039
5.

Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.

Ruocco LA, Carnevale UA, Treno C, Sadile AG, Melisi D, Arra C, Ibba M, Schirru C, Carboni E.

Behav Brain Res. 2010 Jun 26;210(1):99-106. doi: 10.1016/j.bbr.2010.02.020. Epub 2010 Feb 13.

PMID:
20156489
6.

Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex.

Bymaster FP, Zhang W, Carter PA, Shaw J, Chernet E, Phebus L, Wong DT, Perry KW.

Psychopharmacology (Berl). 2002 Apr;160(4):353-61. Epub 2002 Jan 29.

PMID:
11919662
7.

Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex.

Gresch PJ, Sved AF, Zigmond MJ, Finlay JM.

J Neurochem. 1995 Jul;65(1):111-6.

PMID:
7790854
8.

Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat.

Mazei MS, Pluto CP, Kirkbride B, Pehek EA.

Brain Res. 2002 May 17;936(1-2):58-67.

PMID:
11988230
9.

Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex.

Horner WE, Johnson DE, Schmidt AW, Rollema H.

Eur J Pharmacol. 2007 Mar 8;558(1-3):96-7. Epub 2006 Dec 1.

PMID:
17198700
10.

Regulation of extracellular dopamine by the norepinephrine transporter.

Yamamoto BK, Novotney S.

J Neurochem. 1998 Jul;71(1):274-80.

11.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
12.
14.

Effects of atomoxetine on attention and impulsivity in the five-choice serial reaction time task in rats with lesions of dorsal noradrenergic ascending bundle.

Liu YP, Huang TS, Tung CS, Lin CC.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jan 2;56:81-90. doi: 10.1016/j.pnpbp.2014.08.007. Epub 2014 Aug 21.

PMID:
25151304
15.

Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.

Devoto P, Flore G, Pira L, Longu G, Gessa GL.

Eur J Pharmacol. 2004 Mar 8;487(1-3):105-11.

PMID:
15033381
16.

Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.

Liu LL, Yang J, Lei GF, Wang GJ, Wang YW, Sun RP.

Basic Clin Pharmacol Toxicol. 2008 Jun;102(6):527-32. doi: 10.1111/j.1742-7843.2008.00230.x. Epub 2008 Mar 16.

17.

Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level.

Hertel P, Nomikos GG, Svensson TH.

Eur J Pharmacol. 1999 Apr 29;371(2-3):153-8.

PMID:
10357252
18.

Atomoxetine affects transcription/translation of the NMDA receptor and the norepinephrine transporter in the rat brain--an in vivo study.

Udvardi PT, Föhr KJ, Henes C, Liebau S, Dreyhaupt J, Boeckers TM, Ludolph AG.

Drug Des Devel Ther. 2013 Dec 4;7:1433-46. doi: 10.2147/DDDT.S50448. eCollection 2013.

20.

Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test.

Navarra R, Graf R, Huang Y, Logue S, Comery T, Hughes Z, Day M.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):34-41. Epub 2007 Jun 27.

PMID:
17714843
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk